Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
40 participants
INTERVENTIONAL
2018-02-01
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Aggressive Pain Management is Associated With Improved Outcomes in Blunt Thoracic Trauma
NCT01327287
Ultrasound-Guided Serratus Anterior Plane Block for Additional Pain Relief After Lung Surgery
NCT04238455
STUMBL Score as a Risk Stratification Tool for Management of Blunt Chest Trauma Patients
NCT06316375
Evaluation of Patient Analgesia After Bloc Serratus
NCT04123977
Evaluation of Intercostal Neuralgia in Patients With Chest Tube Insertion After Traumatic Rib Fracture
NCT07308587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
2. Group (s) : will receive mixture consisting of 9 ml of 0.125 % bupivacaine with 80mg of triamcinolone ( 10 ml total volume) .through epidural catheter in-T7- T10 .on admission
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
morphine sulfate group
patients in this arm will receive : morphine dose 0.1mg /kg with 9 ml of 0.25 % bupivacaine with through epidural catheter on admission Then continuous epidural infusion of bupivacaine (0.1 mg.kg-1.h) 1st 72 hours
Morphine Sulfate
Thoracic Epidural morphine
triamcinolone acetonide group
patients in this arm will receive will receive a mixture of 9 ml of 0.125 % bupivacaine with 80mg of triamcinolone ( 10 ml total volume) through epidural catheter on admission
Triamcinolone Acetonide
thoracic epidural triamcinolone acetonide
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Morphine Sulfate
Thoracic Epidural morphine
Triamcinolone Acetonide
thoracic epidural triamcinolone acetonide
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical status 1 or 2.
* mentally competent and able to give consent for enrollment in the study
Exclusion Criteria
* Psychiatric disorder
* Patient younger than 18 years old
* Allergy to local anesthetics, systemic opioids (fentanyl, morphine)
* Impaired kidney functions and patient with coagulopathy will be also excluded.
* Chronic pain syndromes and patients with chronic opioid use defined as use of regular daily doses of systemic narcotics for the past 6 months prior to the surgery.
* BMI of 40 or more
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa hassanien hassanien bakr
assitent lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emad Z Saed
Role: PRINCIPAL_INVESTIGATOR
Lecturer. ansethsia department. Faculty of medicine .assuit unveristy.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB1000
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.